Spyre Therapeutics Inc (SYRE)

Investing Cash Flow

-$297.90M

Quarterly · Period ending: · USD

SYRE logo

SYRE Investing Cash Flow

Latest reported-$297.90M
SYRE Quarterly Cash from Investing (-$32.00K → -$297.90M)
High-resolution chart · PNG

SYRE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-297,904,000
56,581,000
-247,410,000
24,998,000
78,998,000
-61,000
-170,544,000
42,740,000
-120,518,000
-104,963,000
-35,272,000
-97,631,000
6,760,000
17,750,000
14,000,000
16,499,000
750,000
25,759,000
9,663,000
5,777,000
-47,359,000
9,300,000
28,620,000
5,784,000
-56,761,000
14,753,000
10,326,000
16,012,000
-42,013,000
13,936,000
-2,132,000
1,399,000
-19,200,000
4,702,000
4,844,000
-6,286,000
4,524,000
-25,611,000
2,559,000
-15,295,000
1,852,000
-1,192,000
-510,000
-3,460,000
-24,000
-20,000
-111,000
-73,000
-5,000
-32,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.